Growth in the cost of biologics in Medicare beneficiaries, 2013 to 2016

被引：3
作者：
Singh, Partik [1 ]
Silverberg, Jonathan I. [2 ,3 ]
机构：
[1] Northwestern Univ, Dept Dermatol, Feinberg Sch Med, Chicago, IL 60611 USA
[2] Northwestern Univ, Dept Prevent Med, Feinberg Sch Med, Chicago, IL 60611 USA
[3] Northwestern Univ, Dept Med Social Sci, Feinberg Sch Med, Chicago, IL 60611 USA
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2019年 / 80卷 / 01期
关键词：
D O I：
10.1016/j.jaad.2018.08.004
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
[No abstract available]
引用
收藏
页码：281 / 282
页数：2
相关论文
共 4 条
[1]  
Centers for Medicare & Medicaid Services, MED PROV UT PAYM D D
[2]   A Systematic Review of US Biosimilar Approvals: What Evidence Does the FDA Require and How Are Manufacturers Responding? [J].
Hung, Anna ;
Quyen Vu ;
Mostovoy, Lisa .
JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2017, 23 (12) :1234-+
[3]   The High Cost of Prescription Drugs in the United States Origins and Prospects for Reform [J].
Kesselheim, Aaron S. ;
Avorn, Jerry ;
Sarpatwari, Ameet .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2016, 316 (08) :858-871
[4]  
US Bureau of Labor Statistics, CPI INFL CALC
1